U.S. Residential REITs Stock News

UnitedHealth Group just delivered a punchy earnings headline while the stock quietly slipped. Shares closed at US$402.20, down about 1.6% on the day and modestly weaker over the past month, even as quarterly adjusted earnings per share landed at US$6.38 and operating earnings rose sharply compared with a year ago. The market looks more cautious than the numbers alone might suggest. Investors seem to be discounting the earnings strength and raised full year guidance, and instead leaning into...

FTAI Infrastructure entered this earnings season with a troubled reputation and low expectations, yet the stock nudged 1.6% higher to about US$4.37 by the close. The market is trying to price in a potential turnaround story while the income statement still shows heavy red ink. Q2 revenue came in at about US$186.8 million, but the company reported a net loss of roughly US$166.5 million and basic earnings per share of a loss of US$1.41. The real headline is not the modest price increase...

Green Dot stock barely flinched after earnings, ticking up about 1% to US$13.41, yet the numbers point to a far more dramatic story than the share price suggests. A consumer finance company that has been wrestling with rising losses just put up one of its cleanest quarterly profit lines in recent memory, with Q1 2026 basic earnings per share at US$0.96 on revenue of US$654.7m. For a business that has reported trailing twelve month net income losses, this kind of earnings power instantly...

Caledonia Mining stock closed up 1.1% at US$22.97, a calm move for what is a punchy set of numbers. The market treated today as a small win. The income statement looks more like a statement of intent. The headline is earnings power. Second quarter basic earnings per share landed at US$1.36 on revenue of about US$72.0m, with net income of US$23.8m. That keeps the trailing twelve month profit picture firm and leaves Caledonia Mining trading on a single digit P/E multiple. Short term traders saw...

Fiserv stock has fallen sharply over the past year, and current valuation checks suggest the shares now lean cheap rather than expensive. With outside investors pushing for portfolio changes and management resetting expectations, the market is weighing how much of the bad news is already in the price. Fiserv has declined 60.2% over the past year, which puts the recent share price weakness at the center of any valuation discussion. On the upside, pressure from JANA Partners for portfolio...

Visa stock has delivered a 60.7% return over the past five years, yet its valuation signals are split. The Excess Returns intrinsic value estimate points to some upside, while traditional market multiples lean the other way and the broader checks do not flag Visa as a clear bargain. Over five years Visa has returned 60.7%. This puts the focus on whether the current share price already reflects much of that progress. Recent moves into stablecoin payment rails and AI driven fraud prevention...

Alpha Tau Medical earnings put recent clinical progress in context Alpha Tau Medical (NasdaqCM:DRTS) has paired a series of high profile clinical and partnership milestones with fresh half year results that show a wider net loss and higher loss per share. The company reported a net loss of US$68.75 million for the half year to June 30, 2026, compared with a loss of US$18.81 million a year earlier. Basic and diluted loss per share from continuing operations were both US$0.76, compared with...

In the past week, Intuitive Surgical reported fiscal Q2 2026 results that exceeded revenue and adjusted EPS forecasts, while also updating its bylaws to align shareholder voting and nomination rules with recent SEC universal proxy requirements. Despite solid global procedure expansion across da Vinci and Ion systems, investors focused on moderating U.S. procedure growth and tighter governance procedures that could shape future shareholder influence and board elections. We’ll now examine how...

Why ACADIA Pharmaceuticals Stock Is Back in Focus After Guidance Update ACADIA Pharmaceuticals (ACAD) put its stock firmly on investors’ radar after raising 2026 earnings guidance and reporting second quarter results that showed higher revenue and net income compared with a year earlier. The company now expects 2026 revenue between US$1.24b and US$1.30b, with NUPLAZID projected at US$760 million to US$790 million and DAYBUE at US$480 million to US$510 million. These updated figures illustrate...

Central banks are talking tougher on inflation, growth forecasts are being cut, and energy markets remain volatile, which puts the spotlight squarely on large energy stocks exposed to these pressures. For investors, this mix of risk and potential resilience can reshape how you think about where to put new money or what to hold. This article breaks down 3 energy stocks affected by the recent news and explains why each may warrant a closer look now. The three stocks covered below are just a...

Bio-Rad Laboratories (BIO) has moved into focus after its second quarter 2026 earnings and fresh guidance, which combined a slight overall revenue decline with firmer contributions from several international markets. See our latest analysis for Bio-Rad Laboratories. The recent guidance and international revenue patterns arrived alongside a sharp shift in sentiment around Bio-Rad Laboratories, with a 46.30% 90 day share price return and a 29.66% 1 year total shareholder return contrasting with...

In early August 2026, The Timken Company reported second-quarter results showing sales rising to US$1,260.9 million from US$1,173.4 million a year earlier, while net income fell to US$28.9 million from US$78.5 million, alongside confirming a US$0.36 quarterly dividend and completing a US$47.97 million share repurchase program. At the same time, Timken raised its 2026 earnings and revenue outlook and reworked its senior leadership team to support its Elevate to Outperform plan, signaling a...

Lockheed Martin stock has delivered an 89.2% return over the past 5 years, yet current valuation work suggests the shares may still trade below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and earnings multiples that both screen as undervalued. That 89.2% 5 year gain means existing shareholders have already seen a strong payoff, so new buyers need to weigh what is already reflected in the price. A multiyear PAC 3 missile production contract and ongoing missile...

In early August 2026, Curio announced a Memorandum of Understanding with NuScale Power and Framatome to assess an integrated, closed-loop nuclear fuel solution using Curio’s NuCycle recycling technology to support domestic and international nuclear fuel supply chains. This collaboration highlights growing industry interest in pairing NuScale’s small modular reactor platform with advanced fuel-cycle technologies that aim to reduce waste volumes and strengthen long-term nuclear energy...

Ichor Holdings, Ltd. reported second-quarter 2026 results showing sales of US$294.78 million and net income of US$0.998 million, a shift from a loss a year earlier, and issued third-quarter revenue guidance of US$315 million to US$345 million with expected GAAP diluted EPS between US$0.25 and US$0.35. These results indicate improved profitability and higher sales compared with the prior year period, while the company’s forward guidance offers investors clearer expectations around revenue and...

With investors glued to upcoming US inflation data, oil price swings and firm Treasury yields, high dividend yield stocks are drawing fresh attention from anyone looking for steadier income while markets debate the Federal Reserve’s next move in September. This article looks at how those macro forces link back to company fundamentals and payout strength. You will see three stocks from the screener that appear positively exposed to the current backdrop. The three stocks highlighted below are...

Apnimed, Inc (NasdaqGS:APMD) has been added to the NASDAQ Composite Index following its recent IPO. The addition comes soon after Apnimed filed a shelf registration statement, signaling further corporate funding flexibility. Index inclusion typically draws attention from index-tracking funds and can affect trading volumes and liquidity. This kind of index move, combined with fresh IPO activity, points to a wider group of stocks that may be worth a closer look through 51 high quality...

Why nVent Electric’s latest earnings and expansion matter for investors nVent Electric (NVT) is in focus after reporting second quarter 2026 earnings, along with new manufacturing expansion plans for its data center liquid cooling business, tied to AI and high-performance computing demand. See our latest analysis for nVent Electric. The latest earnings release and data center expansion news come on top of strong momentum in nVent Electric’s stock, with a year to date share price return of...

Rexford Industrial Realty stock sits in a tricky spot for valuation minded investors. The Discounted Cash Flow (DCF) intrinsic value estimate lines up fairly closely with the current share price, while the market multiple view suggests the stock is trading at a premium and long term returns have been weak. Rexford Industrial Realty shareholders have seen the stock decline about 31% over the past 5 years, which raises questions about how much long term value has actually been created. The...

WaFd stock reaction and recent performance snapshot WaFd (WAFD) did not have a specific news event driving today’s move, yet the stock advanced to a last close of US$38.06, with 1 day and 7 day returns of 2.0% and 1.0%. Over the past month the share price was roughly flat with a slight decline of 0.1%, while the past 3 months show a 10.0% gain and the 1 year total return stands at 29.1%. See our latest analysis for WaFd. At around US$38.06, WaFd’s recent share price strength over the past...

Everest Group stock moves after mixed quarter and fresh shelf registration Everest Group (NYSE:EG) is back in focus after its second quarter 2026 results showed lower revenue and net income compared with a year earlier, alongside a new shelf registration for common stock. See our latest analysis for Everest Group. Everest Group shares trade at US$365.70 after a muted reaction to the second quarter earnings update, with a 90 day share price return of 5.1% and a 1 year total shareholder return...

FIFA’s leadership turmoil and talk of boycotts has put the business of global football under an uncomfortable spotlight, from billion dollar media rights to sponsorships tied to future World Cups. That disruption risk also creates an opening for investors watching sports media and broadcasting stocks exposed to this news. This article breaks down how three stocks from our screener are positioned, so you can judge whether the story fits your portfolio. The stocks covered below are just a...

With the July CPI release putting Federal Reserve rate expectations on a knife edge, interest rate sensitive U.S. REITs suddenly sit at the heart of the story rather than the sidelines. A softer inflation print could support rate relief hopes, while a hotter reading could do the opposite. This article walks through three REIT stocks exposed to that CPI outcome so you can see where opportunity and risk may be building right now. The three REITs below are just a starting sample, since the full...

Piper Sandler’s downgrade of Samsara (IOT) to Neutral after a strong six month share run is putting fresh attention on slowing app-download trends and a bigger reliance on cross-selling for growth. See our latest analysis for Samsara. The downgrade comes after a strong run, with Samsara’s 90 day share price return of 41.85% and 1 year total shareholder return of 22.65% signaling momentum that is now starting to cool after today’s share price pullback. If this shift in sentiment has you...